Document Detail


Influence of the site of arterial occlusion on multiple baseline hemodynamic MRI parameters and post-thrombolytic recanalization in acute stroke.
MedLine Citation:
PMID:  15517229     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In this prospective MRI study, we evaluated the impact of the site of occlusion on multiple baseline perfusion parameters and subsequent recanalization in 49 stroke patients who were given intravenous tissue plasminogen activator (tPA). Pretreatment magnetic resonance angiography (MRA) revealed an arterial occlusion in 47 patients: (1) internal carotid artery (ICA) + M1 middle cerebral artery (MCA) occlusion (n=12); (2) M1 MCA occlusion (n=19); (3) M2 MCA, distal branches of the MCA and anterior cerebral artery (ACA) occlusion (n=16). Patients with ICA occlusion had significantly larger DWI, PWI and mismatch lesion volume on pretreatment MRI compared to patients with other sites of occlusion. The differences in cerebral blood flow (CBF) and peak height were significantly higher in patients with ICA occlusion compared to patients with other sites of occlusion (P=0.03 and P=0.04, respectively). Day 1 MRA showed recanalization in 28 patients (60%). The rate of recanalization was significantly different depending on the site of occlusion: 33% in ICA + M1 MCA occlusion, 63% in M1 MCA occlusion and 81% in either M2 MCA, distal branches of the MCA or ACA occlusion (P=0.002). Our data suggest that CBF and peak height are the most relevant MRI parameters to assess the severity of hemodynamic impairment in regard to the site of occlusion.
Authors:
L Derex; M Hermier; P Adeleine; J B Pialat; M Wiart; Y Berthezène; J C Froment; P Trouillas; N Nighoghossian
Related Documents :
7946689 - Intraarterial occlusion by radiofrequency.
20824749 - Subintimal angioplasty with a true reentry device for treatment of chronic total occlus...
19683769 - Temporary segmental renal artery occlusion using reverse phase polymer for bloodless ro...
2742289 - Idiopathic bilateral branch-artery occlusion in a young woman.
12499529 - Triple wire technique for a bifurcation lesion and a subtotal occlusive lesion.
2067589 - Release of endogenous catecholamines in two different regions of the nucleus of the sol...
1463669 - Delayed rupture of an internal iliac artery aneurysm following proximal ligation for ab...
11930659 - Coronary bypass revascularization with radial artery and internal mammary artery grafts.
8133549 - Two independent intracranial arteriovenous malformations: a case report.
Publication Detail:
Type:  Journal Article     Date:  2004-10-29
Journal Detail:
Title:  Neuroradiology     Volume:  46     ISSN:  0028-3940     ISO Abbreviation:  Neuroradiology     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-12-20     Completed Date:  2005-03-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1302751     Medline TA:  Neuroradiology     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  883-7     Citation Subset:  IM    
Affiliation:
Service d'Urgences NeuroVasculaires, Hôpital Neurologique, 59 Boulevard Pinel, 69003, Lyon, France. laurent.derex@chu-lyon.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Brain Ischemia / complications,  physiopathology*
Carotid Stenosis / complications,  diagnosis*,  drug therapy
Cerebrovascular Circulation / physiology*
Female
Fibrinolytic Agents / therapeutic use
Humans
Intracranial Thrombosis / complications,  diagnosis*,  drug therapy
Magnetic Resonance Angiography
Male
Middle Aged
Prospective Studies
Stroke / etiology,  physiopathology*
Tissue Plasminogen Activator / therapeutic use
Treatment Outcome
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Central neurocytoma: a clinicopathological and neuroradiological study.
Next Document:  Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate c...